Selected article for: "analysis random effect model and random effect model"
Author: Alsagaff, Mochamad Yusuf; Mulia, Eka Prasetya Budi; Maghfirah, Irma; Luke, Kevin; Nugraha, David; Rachmi, Dita Aulia; Septianda, Imanita; A'yun, Maya Qurota
Title: Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis
  • Cord-id: alyqpvj1
  • Document date: 2021_7_16
    • ID: alyqpvj1
    Snippet: AIMS: This meta-analysis aims to analyze the association of calcium channel blocker (CCB) use with COVID-19 clinical outcomes. METHODS: PubMed, ProQuest, Science Direct, Scopus, and medRxiv databases were searched systematically in a limited period. The primary outcome was mortality. RESULTS: A total of 119,298 patients from 31 eligible studies were included. Pooled analysis of the random-effect model revealed CCB was not associated with reduced mortality (OR = 1.21 [95%CI: 0.98–1.49], p = 0.0
    Document: AIMS: This meta-analysis aims to analyze the association of calcium channel blocker (CCB) use with COVID-19 clinical outcomes. METHODS: PubMed, ProQuest, Science Direct, Scopus, and medRxiv databases were searched systematically in a limited period. The primary outcome was mortality. RESULTS: A total of 119,298 patients from 31 eligible studies were included. Pooled analysis of the random-effect model revealed CCB was not associated with reduced mortality (OR = 1.21 [95%CI: 0.98–1.49], p = 0.08). Interestingly, subgroup analysis in hypertensive patients revealed significantly reduced mortality (OR = 0.69 [95%CI: 0.52–0.91], p = 0.009). CONCLUSION: CCB usage was not associated with the outcome of COVID-19. However, CCB was associated with a decreased mortality rate in hypertensive COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and long term prognosis: 1
    • acute ards respiratory distress syndrome and low certainty: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory disease and adjust patient: 1, 2
    • acute respiratory disease and long term prognosis: 1
    • acute respiratory disease and low certainty: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory disease and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • acute respiratory disease and low respiratory disease: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory disease and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory distress syndrome and adequate evidence: 1
    • acute respiratory distress syndrome and administration type: 1, 2
    • acute respiratory distress syndrome and long term prognosis: 1, 2, 3
    • acute respiratory distress syndrome and low certainty: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
    • acute respiratory distress syndrome and low respiratory disease: 1
    • acute respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • additional relevant study and low certainty: 1